Ebola vaccine

Featured image about Ebola vaccine development showing an Ebola vaccine vial, virus illustration, syringe, laboratory setting, and key data including 100% estimated efficacy in the Guinea ring-vaccination trial, 98% real-world effectiveness in DRC outbreak analysis, 518,890 stockpiled doses, and ongoing challenges such as species gaps, durability, and vaccine deployment.
Ebola

Why there is still no Universal Ebola Vaccine

Ebola vaccine development has made major progress, moving from experimental research to licensed vaccines and real-world outbreak control. Yet important challenges remain, including limited protection across all Ebola species, uncertain durability of immunity, and the difficulty of testing vaccines during unpredictable outbreaks.

Scroll to Top